Legato Capital Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Sell |
13,872
-14,103
| -50% | -$1.04M | 0.12% | 269 |
|
|
2025
Q1 | $3.2M | Sell |
27,975
-4,341
| -13% | -$496K | 0.43% | 44 |
|
|
2024
Q4 | $1.63M | Sell |
32,316
-1,725
| -5% | -$86.9K | 0.21% | 146 |
|
|
2024
Q3 | $1.58M | Buy |
34,041
+9,985
| +42% | +$462K | 0.19% | 167 |
|
|
2024
Q2 | $782K | Buy |
24,056
+8,680
| +56% | +$282K | 0.11% | 323 |
|
|
2024
Q1 | $387K | Hold |
15,376
| – | – | 0.05% | 478 |
|
|
2023
Q4 | $499K | Hold |
15,376
| – | – | 0.07% | 416 |
|
|
2023
Q3 | $419K | Sell |
15,376
-6,125
| -28% | -$167K | 0.06% | 434 |
|
|
2023
Q2 | $478K | Hold |
21,501
| – | – | 0.06% | 427 |
|
|
2023
Q1 | $466K | Hold |
21,501
| – | – | 0.08% | 369 |
|
|
2022
Q4 | $437K | Buy |
+21,501
| New | +$437K | 0.08% | 372 |
|